| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |